CCM
Camber Capital Management Portfolio holdings
AUM
$718M
1-Year Return
4.23%
This Quarter Return
+5.2%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.04B
AUM Growth
-$1.26M
(-0.12%)
Cap. Flow
-$53.5M
Cap. Flow
% of AUM
-5.13%
Top 10 Holdings %
Top 10 Hldgs %
55.95%
Holding
45
New
9
Increased
10
Reduced
13
Closed
6
Top Buys
| 1 |
Haemonetics
HAE
|
$39.2M |
| 2 |
Labcorp
LH
|
$36.8M |
| 3 |
Community Health Systems
CYH
|
$29.4M |
| 4 |
Tenet Healthcare
THC
|
$25.7M |
| 5 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$23.1M |
Top Sells
| 1 |
Viatris
VTRS
|
$73.2M |
| 2 |
Merck
MRK
|
$49.6M |
| 3 |
UnitedHealth
UNH
|
$28.7M |
| 4 |
Agilent Technologies
A
|
$28.6M |
| 5 |
HCA Healthcare
HCA
|
$23.6M |
Sector Composition
| 1 | Healthcare | 87.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Viatris
VTRS
$12.2B
| $12.2M | 0.96% |
250,000
-1,500,000
| -86% | -$73.2M |
|
|
NXTM
27
DELISTED
NxStage Medical Inc.
NXTM
| $10.5M | 0.82% |
820,535
| – | – |
|
28
Novavax
NVAX
$1.28B
| $10.2M | 0.8% |
112,500
-62,500
| -36% | -$5.66M |
|
29
Geron
GERN
$893M
| $9.82M | 0.77% |
4,972,600
+3,385,600
| +213% | +$6.69M |
|
|
RVNC
30
DELISTED
Revance Therapeutics, Inc.
RVNC
| $9.45M | 0.74% |
+300,000
| New | +$9.45M |
|
31
Protalix BioTherapeutics
PLX
$123M
| $9.16M | 0.72% |
200,000
| – | – |
|
|
GNMK
32
DELISTED
GenMark Diagnostics, Inc
GNMK
| $9.03M | 0.71% |
908,100
-41,900
| -4% | -$417K |
|
33
Gyre Therapeutics
GYRE
$698M
| $7.41M | 0.58% |
1,981
+1,746
| +743% | +$6.53M |
|
|
SQNM
34
DELISTED
SEQUENOM INC NEW
SQNM
| $7.13M | 0.56% |
+2,911,520
| New | +$7.13M |
|
|
BIOL
35
DELISTED
Biolase, Inc.
BIOL
| $6.54M | 0.51% |
217
| – | – |
|
36
AngioDynamics
ANGO
$436M
| $6.49M | 0.51% |
411,930
-588,070
| -59% | -$9.26M |
|
|
MNTA
37
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $4.66M | 0.37% |
400,000
-400,000
| -50% | -$4.66M |
|
38
Cross Country Healthcare
CCRN
$462M
| $2.49M | 0.2% |
308,542
-1,231,458
| -80% | -$9.94M |
|
|
39
Agilent Technologies
A
$36.5B
| – | – |
-699,000
| Closed | -$28.6M |
|
40
Arrowhead Research
ARWR
$4.02B
| – | – |
-1,500,000
| Closed | -$16.3M |
|
41
Edwards Lifesciences
EW
$47.5B
| – | – |
-2,100,000
| Closed | -$23M |
|
|
42
Merck
MRK
$212B
| – | – |
-1,037,834
| Closed | -$49.6M |
|
43
SPDR S&P 500 ETF Trust
SPY
$660B
| – | – |
0
| – | – |
|
|
XNPT
44
DELISTED
XENOPORT, INC.
XNPT
| – | – |
-1,000,000
| Closed | -$5.75M |
|
|
DSCI
45
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| – | – |
-497,000
| Closed | -$5.38M |
|